Suchergebnisse - "Monteil, Vanessa"

PubPharm (53)

11

Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients

enthalten in: ResearchSquare.com | 2022

von Stebbing, J. | Krishnan, V. | de Bono, S. | +14

12

A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells

enthalten in: Cell metabolism | 2022

von Garreta, E. | Prado, P. | Stanifer, M. | +24

CommentIn: Kidney Int. 2022 Nov;102(5):951-953. - PMID 35963447

13

A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells

enthalten in: Cell metabolism | 12 May 2022

von Garreta, E. | Prado, P. | Stanifer, M. | +24

14

Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity

enthalten in: Cell | 2022

von Batlle, D. | Monteil, V. | Garreta, E. | +8

CommentOn: Cell. 2021 Apr 15;184(8):2212-2228.e12. - PMID 33713620

15

Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo Hemorrhagic Fever Viruses for novel therapeutic target

enthalten in: bioRxiv.org | 2022

von Neogi, U. | Elaldi, N. | Appelberg, S. | +14

16

Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor

enthalten in: bioRxiv.org | 2022

von Capraz, T. | Kienzl, N. | Laurent, E. | +13

17

Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target

enthalten in: eLife | 2022

von Neogi, U. | Elaldi, N. | Appelberg, S. | +14

18

Methods of Inactivation of Highly Pathogenic Viruses for Molecular, Serology or Vaccine Development Purposes

enthalten in: Pathogens (Basel, Switzerland) | 2022

von Elveborg, S. | Monteil, V. | Mirazimi, A.

19

Nucleoside-Modified mRNA Vaccines Protect IFNAR-/- Mice against Crimean-Congo Hemorrhagic Fever Virus Infection

enthalten in: Journal of virology | 2022

von Appelberg, S. | John, L. | Pardi, N. | +12

20

Clinical grade ACE2 as a universal agent to block SARS‐CoV‐2 variants

enthalten in: EMBO Molecular Medicine | 2022

von Monteil, V. | Eaton, B. | Postnikova, E. | +32